GENOWAY
genOway is a biotechnology company that specializes in developing genetically modified research models with strong added value for the biopharmaceutical industries and academic researches. genOway is a leader in its market. It builds its development on the combination of a large and exclusive technological platform and a strong intellectual property combining operating patents and licenses. genOway struck several commercial contracts with pharmaceutical industry leaders (Janssen R&D, GSK, Pfizer, etc.), and with the most prestigious academic research centers (King's College and Manchester in England, Harvard, Caltech and National Institute of Health in the United States, the Institut Pasteur in France, the NGFN, etc.).
GENOWAY
Industry:
Biopharma Biotechnology Health Care
Founded:
1999-01-01
Address:
Lyon, Rhone-Alpes, France
Country:
France
Website Url:
http://www.genoway.com
Total Employee:
51+
Status:
Active
Contact:
+33 (0)4 37 65 41 00
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Nginx
Similar Organizations
Abbexa
Abbexa is a dedicated supplier of biological tools for scientific research.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Vical
Vical develops biopharmaceutical drugs to prevent and treat chronic or life-threatening infectious diseases.
Stock Details
Official Site Inspections
http://www.genoway.com Semrush global rank: 4.1 M Semrush visits lastest month: 2.96 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "genOway"
genOway - Crunchbase Company Profile & Funding
GenOway is a biotechnology company that specializes in developing genetically modified research models with strong added value for the biopharmaceutical โฆSee details»
Preclinical mouse, rat & cell lines for ultimate โฆ
At genOway, we recognize the crucial role that preclinical research plays in the success of new therapies in clinical settings. Our team of experts brings together decades of experience in designing genetically modified models and a โฆSee details»
Corporate overview - company profile & board of directors
GenOway generated more than 2000 genetically-modified models in the past 19 years while working with more than 170 Life Sciences companies and 380 academic institutes. ... of the โฆSee details»
genOway - The Org
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models โฆSee details»
genOway - LinkedIn
GenOway | 6,675 followers on LinkedIn. Ultimate predictability | Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative ...See details»
GenOway - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 20, 2025 GenOway - Provider of transgenic rodent models and customized cell lines for preclinical development. Public Company. Raised a total funding of $11.6M over 5 rounds โฆSee details»
genOway Company Overview, Contact Details & Competitors
GenOway. Biotechnology Research Auvergne-Rhône-Alpes, France 51-200 Employees. Founded in 1999, genOway is a global biotechnology company dedicated to the development and โฆSee details»
genOway Company Profile - Office Locations, Competitors, โฆ
Oct 29, 2024 genOway has 5 employees at their 1 location and โฌ20.05 m in annual revenue in FY 2023. See insights on genOway including office locations, competitors, revenue, financials, โฆSee details»
genOway Société anonyme Company Description - Stock Analysis
Mar 14, 2025 genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line โฆSee details»
genOway - Funding, Financials, Valuation & Investors - Crunchbase
May 4, 2007 genOway develop the most adapted, highly physiologically relevant genetically modified rodent models for each research program. ... Experience the new Crunchbase, โฆSee details»
โ๏ธGenOway SA โ Consulting Organization from
Dec 6, 2024 Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and โฆSee details»
Genoway SA, JEH:FRA profile - FT.com - Financial Times
Mar 3, 2025 Genoway SA is a France-based company which is specializes in the provision of genetically modified mouse and rat models for biopharmaceutical companies, laboratories and โฆSee details»
News - genoway.com
Lyon, France โ February 21, 2025 โ genOway is a biotechnology company specializing in the development of predictive preclinical solutions (better mimicking human physiology and โฆSee details»
SIGMA-ALDRICH AND GENOWAY EXPAND THEIR CRISPR/CAS9 โฆ
Sep 8, 2022 About genOway. Founded in 1999, genOway is a biotechnology company whose goal is to accelerate innovation in medical research by providing researchers and industry with โฆSee details»
genOway grants the leading UK academic research funder a non
Jan 25, 2022 /CNW/ -- genOway, a world leader in the field of genetically modified innovative research models, ... Organization Profile. genOway. Contact Cision. 866-245-2317 from 8 AM โฆSee details»
genOway | Lab Animal Buyers' Guide
GenOway. Description Our activities focus on mouse, rat and cell line genetical modifications by combining technologies routinely used in genome engineering with a range of innovative โฆSee details»
genOway SA (genOway SA) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ
May 1, 2023 This improved alliance should enable genOway and Sigma to better serve their clients and consequently strongly support innovation in the preclinical field," says Alexandre โฆSee details»
Contact us - genOway
We appreciate media interest in our company, and encourage media inquiries to be directed to [email protected]. This will ensure that your inquiry reaches the appropriate department โฆSee details»
GENOWAY (EPA:ALGEN) | Résultats annuels 2024 - genOway โฆ
3 days ago genOway publie ses résultats financiers annuels 2024 : EBITDA de 4,4 Mโฌ avec une marge de 20,1%, résultat net de 1,8 Mโฌ en progression. ... (Customer Research Organization) โฆSee details»
genOway accélère le déploiement de son plan stratégique ROUTE 50
3 days ago (Boursier.com) โ genOway publie un EBITDA de 4,4 Mโฌ ainsi qu'une marge d'EBITDA à 20,1%. Le Résultat net est de 1,8 Mโฌ (+17%), la Marge nette ressortant à 8,3%. โฆSee details»